Relmada Therapeutics Statistics
Total Valuation
RLMD has a market cap or net worth of $125.52 million. The enterprise value is $41.91 million.
| Market Cap | 125.52M |
| Enterprise Value | 41.91M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RLMD has 30.17 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Shares Outstanding | 30.17M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 8.04% |
| Owned by Institutions (%) | 49.22% |
| Float | 27.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.74 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.83, with zero debt.
| Current Ratio | 6.83 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -102.10% and return on invested capital (ROIC) is -136.77%.
| Return on Equity (ROE) | -102.10% |
| Return on Assets (ROA) | -91.30% |
| Return on Capital (ROIC) | -136.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.71M |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +51.27% in the last 52 weeks. The beta is 0.50, so RLMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +51.27% |
| 50-Day Moving Average | 3.30 |
| 200-Day Moving Average | 3.79 |
| Relative Strength Index (RSI) | 66.95 |
| Average Volume (20 Days) | 119,771 |
Short Selling Information
The latest short interest is 1.01 million, so 3.36% of the outstanding shares have been sold short.
| Short Interest | 1.01M |
| Short Previous Month | 1.55M |
| Short % of Shares Out | 3.36% |
| Short % of Float | 3.65% |
| Short Ratio (days to cover) | 11.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -98.54M |
| Pretax Income | -94.30M |
| Net Income | -94.30M |
| EBITDA | -94.30M |
| EBIT | -94.30M |
| Earnings Per Share (EPS) | -$3.12 |
Balance Sheet
The company has $83.61 million in cash and no debt, giving a net cash position of $83.61 million or $2.77 per share.
| Cash & Cash Equivalents | 83.61M |
| Total Debt | n/a |
| Net Cash | 83.61M |
| Net Cash Per Share | $2.77 |
| Equity (Book Value) | 72.05M |
| Book Value Per Share | 2.39 |
| Working Capital | 72.00M |
Cash Flow
| Operating Cash Flow | -48.19M |
| Capital Expenditures | n/a |
| Free Cash Flow | -48.19M |
| FCF Per Share | -$1.60 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | -0.11% |
| Earnings Yield | -75.12% |
| FCF Yield | -38.39% |
Analyst Forecast
The average price target for RLMD is $2.00, which is -51.92% lower than the current price. The consensus rating is "Strong Sell".
| Price Target | $2.00 |
| Price Target Difference | -51.92% |
| Analyst Consensus | Strong Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:4.
| Last Split Date | Sep 30, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |